The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Have you had your Primary Bid shares come through to you yet?
I’ve still not had mine.
I agree.
Interesting that the investor presentation is during U.K. market hours, not afterwards, or am I reading too much into the timing?
I was wrong! (Happy to have been so as well).
Great to see another positive RNS in line with Sir Al’s timeline.
Even more for him to talk about on Thursday :-)
That’s a fair point, it does feel like the goalposts have moved slightly and a perceived progress vaccuum will lead the shares a little lower in the short term.
I’m fully loaded here now so for me it’s just a case of waiting and coming back in 6/12/18 months.
Problem is I’m addicted to this BB!
I’m registered and looking forward to it.
However I don’t agree that it means that there’ll be an RNS beforehand (although I hope there will be).
There’s enough to talk about without one, so I hope people aren’t pinning their hopes on one before Thursday evening..
As much as I’d like it this week, I’d prefer it on the 23rd June so I win the competition!
Spreadex.
Looking like within the next 2 months, exciting times!
Hah ok no probs.
As you say, still positive though!
On IG just now it confirms that 100% are long and 11 - 50 client accounts with open positions expect the price to rise.
It also says 78% were buys over the last month.
What do we want?
Time travel
When do we want it?
It doesn’t matter.
;-)
Rich!
23rd June.
Great idea, and nice gesture!
Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial
Southampton, UK - 28 May 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, is pleased to announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients has now been completed.
The COVID-19 study
Synairgen's clinical trial in COVID-19 patients (SG016) is a double-blind, placebo-controlled trial. The 220 patient trial comprises 100 patients initiated in hospital and 120 patients initiated in the home setting. The patients participating in the hospital setting have been recruited across a number of NHS trusts and the trial has been adopted by the NIHR Respiratory Translational Research Collaboration which is comprised of leading centres in respiratory medicine in the UK whose internationally recognised experts are working together to accelerate development and discovery for COVID-19. A successful outcome will inform onwards progression of SNG001 in COVID-19 patients. Results from the hospital setting are expected in July 2020, as announced in the Company's Preliminary Results statement on 26 May 2020.
Richard Marsden, CEO of Synairgen, commented: "We are pleased to have now completed recruitment in this important study, with initial trial data expected in July 2020. A successful outcome from this trial could be a critical step towards strengthening the fight against the COVID-19 pandemic."
I’ve been reading this BB for last couple of months and have bought some from
65p up to £1.40 earlier this week.
I’ve taken note of some posters comments (thank you) but I have done my own research too, working in Finance helps a bit, but having dabbled in the market for 20 years I’ve realised I don’t know much and have had some massive fails, thankfully got lucky a few times - this seems to me to be one of the lucky choices.
We’re not there yet, but the story is building, and I also feel that this could be a huge success.
Thank you to the top posters, and also those with a good sense of humour - smiling makes us human!
I do wonder if there’s too much focus on the SP, as opposed to looking at Market Cap compared to potential (note potential so not a done deal yet!) income.
£20 share prices could seem ridiculous now give it was sub 20p in Jan, but that’s backward looking.
The MMs are managing this well so far, but there could be days ahead where it drops 30,40,50p or more as a tree shake, if you believe then hold till the end of next year as a minimum and then decide what to do.
Ps if you believe, wondering why would you take out your initial stake, it just reduces future profit (only if you’re right!) so as ever DYOR.
GLA and here’s to a well researched and enjoyable BB this long weekend.
PPS Jonesrichard, you’ve taken some stick for your SP forecasts, but every week you get a little close, I am sure you will remain humble when you are proved right ;-)
Apparently quickest vaccine previously was 4 years for Mumps.
Just wondered if we have had any Sunday press?
Just wondered if we have had any Sunday press?
Mentioned at the end more on this story (Synairgen trial) on Panorama tomorrow night.
Elucigene's executive management team have agreed to roll approximately 60 per cent. of their shareholdings in Elucigene (representing approximately 20 per cent. of Elucigene's total issued share capital) into new Ordinary Shares in Yourgene. The Consideration Shares to be issued to such members of the Elucigene's executive management team will be subject to lock-up restrictions for a period of 12 months.
In connection with the Fundraise, each of the Directors has agreed to 12 month lock-up restrictions in respect of all Ordinary Shares held by him/her as at the date of this Announcement (and including, in the case of Bill Chang and Lyn Rees, their respective Subscription Shares).